Patents by Inventor Jan Fagerberg

Jan Fagerberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic Compounds For Treatment Of Adrenal Cancer
    Publication number: 20230105457
    Abstract: The present invention relates to antigen-based immunotherapy targeting interleukin 13 receptor alpha 2 (IL13RA2), BIRC5 and/or FOXM1 for treatment of adrenal cancers. In particular, the present invention provides the use of a (poly)peptide comprising an epitope of IL13RA2, BIRC5 and/or FOXM1 or a sequence variant thereof for treatment of an adrenal cancer. Moreover, the present invention also provides combinations of the (poly)peptide comprising an epitope of IL13RA2, BIRC5 and/or FOXM1 or a sequence variant thereof with (poly)peptides comprising other epitopes or sequence variants thereof for treatment of adrenal cancers.
    Type: Application
    Filed: October 16, 2020
    Publication date: April 6, 2023
    Applicant: ENTEROME S.A.
    Inventors: Laurent CHENE, Jan FAGERBERG
  • Methods for identifying patients who will respond well to cancer treatment
    Publication number: 20100190694
    Abstract: The invention provides methods for identifying patients who will respond well to cancer treatment with a therapeutic regimen that comprises the use of a histone deacetylase inhibitor (HDACi) and one or more further chemotherapeutic agents. The invention also relates to methods of treating such patients with a therapeutic regimen comprising the use of a histone deacetylase inhibitor (HDACi) and one or more further chemotherapeutic agents.
    Type: Application
    Filed: January 14, 2010
    Publication date: July 29, 2010
    Inventor: Jan Fagerberg